Volume 61, Issue 1 e202111461
Communication
Open Access

Truly-Biocompatible Gold Catalysis Enables Vivo-Orthogonal Intra-CNS Release of Anxiolytics

Dr. M. Carmen Ortega-Liebana

Dr. M. Carmen Ortega-Liebana

Cancer Research UK Edinburgh Centre, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, EH4 2XU UK

These authors contributed equally to this work.

Search for more papers by this author
Dr. Nicola J. Porter

Dr. Nicola J. Porter

Centre for Discovery Brain Sciences, The Chancellor's Building, University of Edinburgh, Edinburgh, EH16 4SB UK

These authors contributed equally to this work.

Search for more papers by this author
Dr. Catherine Adam

Dr. Catherine Adam

Cancer Research UK Edinburgh Centre, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, EH4 2XU UK

Search for more papers by this author
Dr. Teresa Valero

Dr. Teresa Valero

Cancer Research UK Edinburgh Centre, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, EH4 2XU UK

Search for more papers by this author
Dr. Lloyd Hamilton

Dr. Lloyd Hamilton

Centre for Discovery Brain Sciences, The Chancellor's Building, University of Edinburgh, Edinburgh, EH16 4SB UK

Search for more papers by this author
Dr. Dirk Sieger

Dr. Dirk Sieger

Centre for Discovery Brain Sciences, The Chancellor's Building, University of Edinburgh, Edinburgh, EH16 4SB UK

Search for more papers by this author
Prof. Catherina G. Becker

Prof. Catherina G. Becker

Centre for Discovery Brain Sciences, The Chancellor's Building, University of Edinburgh, Edinburgh, EH16 4SB UK

Center for Regenerative Therapies, Technische Universität Dresden, 01307 Dresden, Germany

Search for more papers by this author
Prof. Asier Unciti-Broceta

Corresponding Author

Prof. Asier Unciti-Broceta

Cancer Research UK Edinburgh Centre, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, EH4 2XU UK

Search for more papers by this author
First published: 03 November 2021
Citations: 24

Graphical Abstract

Making drugs in the brain! Fully-biocompatible Au catalysis enables for the first time the localized uncaging of a neuroactive agent, the anxiolytic drug fluoxetine, directly in the head of zebrafish by using catalytically-enhanced Au-polymer composites as safe catalytic reactors.

Abstract

Being recognized as the best-tolerated of all metals, the catalytic potential of gold (Au) has thus far been hindered by the ubiquitous presence of thiols in organisms. Herein we report the development of a truly-catalytic Au-polymer composite by assembling ultrasmall Au-nanoparticles at the protein-repelling outer layer of a co-polymer scaffold via electrostatic loading. Illustrating the in vivo-compatibility of the novel catalysts, we show their capacity to uncage the anxiolytic agent fluoxetine at the central nervous system (CNS) of developing zebrafish, influencing their swim pattern. This bioorthogonal strategy has enabled -for the first time- modification of cognitive activity by releasing a neuroactive agent directly in the brain of an animal.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.